In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

Journal of Experimental Medicine

Volumn 199, Issue 11, 2004, Pages 1455-1465

  Tang, Qizhi ^a   Henriksen, Kammi J ^a   Bi, Mingying ^a   Finger, Erik B ^a   Szot, Greg ^a   Ye, Jianqin ^a   Masteller, Emma L ^a   McDevitt, Hugh ^b   Bonyhadi, Mark ^c   Bluestone, Jeffrey A ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CYCLACEL LTD   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimnmnity; CD4+CD25+ T cells; Immunoregulation; NOD mice; Tolerance

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL SURFACE; DIABETES MELLITUS; EFFECTOR CELL; GRAFT REJECTION; IMMUNOREGULATION; IMMUNOTHERAPY; IN VITRO STUDY; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD4; AUTOANTIGENS; DIABETES MELLITUS, TYPE 1; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY;

EID: 2942642383     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20040139     Document Type: Article

References (53)

1. Waterhouse, P., J.M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K.P. Lee, C.B. Thompson, H. Griesser, and T.W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 270:985-988.
2. Tivol, E.A., F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, and A.H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:541-547.
3. Kulkarni, A.B., C.G. Huh, D. Becker, A. Geiser, M. Lyght, K.C. Flanders, A.B. Roberts, M.B. Sporn, J.M. Ward, and S. Karlsson. 1993. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA. 90:770-774.
4. Shull, M.M., I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 359:693-699.
5. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057-1061.
6. + T regulatory cells. Nat. Immunol. 4:337-342.
7. + regulatory T cells. Nat. Immunol. 4:330-336.
8. + immunoregulatory T cells that control autoimmune diabetes. Immunity. 12:431-440.
9. Belghith, M., J.A. Bluestone, S. Barriot, J. Megret, J.F. Bach, and L. Chatenoud. 2003. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. 9:1202-1208.
10. Ueda, H., J.M. Howson, L. Esposito, J. Heward, H. Snook, G. Chamberlain, D.B. Rainbow, K.M. Hunter, A.N. Smith, G. Di Genova, et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 423:506-511.
11. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182:18-32.
12. Chatenoud, L., B. Salomon, and J.A. Bluestone. 2001. Suppressor T cells-they're back and critical for regulation of autoimmunity! Immunol. Rev. 182:149-163.
13. Wood, K.J., and S. Sakaguchi. 2003. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3:199-210.
14. Singh, B., S. Read, C. Asseman, V. Malmstrom, C. Mottet, L.A. Stephens, R. Stepankova, H. Tlaskalova, and F. Powrie. 2001. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182:190-200.
15. Curotto de Lafaille, M.A., and J.J. Lafaille. 2002. CD4(+) regulatory T cells in autoimmunity and allergy. Curr. Opin. Immunol. 14:771-778.
16. + thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse. J. Immunol. 161:2620-2628.
17. + T cells that prevent diabetes onset in nonobese diabetic mice. J. Immunol. 164:240-247.
18. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303-310.
19. Shimizu, J., S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi. 2002. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3:135-142.
20. McHugh, R.S., M.J. Whitters, C.A. Piccirillo, D.A. Young, E.M. Shevach, M. Collins, and M.C. Byrne. 2002. CD4(+) CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 16:311-323.
21. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192:295-302.
22. Taylor, P.A., C.J. Lees, and B.R. Blazar. 2002. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 99:3493-3499.
23. + regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 196:389-399.
24. + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat. Med. 9:1144-1150.
25. Lohr, J., B. Knoechel, S. Jiang, A.H. Sharpe, and A.K. Abbas. 2003. The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nat. Immunol. 4:664-669.
26. Graca, L., S.P. Cobbold, and H. Waldmann. 2002. Identification of regulatory T cells in tolerated allografts. J. Exp. Med. 195:1641-1646.
27. Asseman, C., S. Mauze, M.W. Leach, R.L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190:995-1004.
28. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168:1080-1086.
29. + regulatory T cells control Leishmania major persistence and immunity. Nature. 420:502-507.
30. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287-296.
31. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196:237-246.
32. + T cells with regulatory properties from human blood. J. Exp. Med. 193:1303-1310.
33. Apostolou, I., A. Sarukhan, L. Klein, and H. von Boehmer. 2002. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3:756-763.
34. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193:1295-1302.
35. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193:1285-1294.
36. + T suppressor cell clones produce transforming growth factor β, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 196:1335-1346.
37. Barthlott, T., G. Kassiotis, and B. Stockinger. 2003. T cell regulation as a side effect of homeostasis and competition. J. Exp. Med. 197:451-460.
38. Stockinger, B., T. Barthlott, and G. Kassiotis. 2001. T cell regulation: a special job or everyone's responsibility? Nat. Immunol. 2:757-758.
39. Kukreja, A., G. Cost, J. Marker, C. Zhang, Z. Sun, K. Lin-Su, S. Ten, M. Sanz, M. Exley, B. Wilson, et al. 2002. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109:131-140.
40. Gregori, S., N. Giarratana, S. Smiroldo, and L. Adorini. 2003. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J. Immunol. 171:4040-4047.
41. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198:235-247.
42. + T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer. J. Exp. Med. 196:481-492.
43. Masteller, E.L., M.R., Warner, W. Ferlin, V. Judkowski, D. Wilson, N. Glaichenhaus, and J.A. Bluestone. 2003. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes. J. Immunol. 171:5587-5595,
44. Lenschow, D.J., Y. Zeng, K.S. Hathcock, L.A. Zuckerman, G. Freeman, J.R. Thistlethwaite, G.S. Gray, R.J. Hodes, and J.A. Bluestone. 1995. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation. 60:1171-1178.
45. Gavin, M.A., S.R. Clarke, E. Negrou, A. Gallegos, and A. Rudensky. 2002. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat. Immunol. 3:33-41.
46. + regulatory T cells. J. Immunol. 171:3348-3352.
47. Kanagawa, O., A. Militech, and B.A. Vaupel. 2002. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice. J. Immunol. 168:6159-6164.
48. Qin, S., S.P. Cobbold, H. Pope, J. Elliott, D. Kioussis, J. Davies, and H. Waldmann. 1993. "Infectious" transplantation tolerance. Science. 259:974-977.
49. Chen, Z.K., S.P. Cobbold, H. Waldmann, and S. Metcalfe. 1996. Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation. 62:1200-1206.
50. + T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J. Immunol. 169:5401-5404.
51. + autoreactive T cells in T1D using HLA class II tetramers. Ann. NY Acad. Sci. 1005:82-87.
52. Eisenbarth, G.S., and G.T. Nepom. 2002. Class II peptide multimers: promise for type 1A diabetes? Nat. Immunol. 3:344-345.
53. + T cells. Clin. Immunol. 106:16-22.